NEW YORK – Personalis said Wednesday that it has priced its recently announced public offering of 6,578,947 shares of its common stock at $19 per share. It expects gross proceeds to be about $125 million.
The company, which has commercialized a suite of next-generation sequencing services for population genomics and cancer diagnostics research, didn't detail its intended use of proceeds from the offering.
BofA Securities, Citigroup and Cowen are acting as joint book-running managers. BTIG, Needham & Company and Oppenheimer & Co. are acting as co-managers.